President Joe Biden and Sen. Bernie Sanders in a Tuesday op-ed in USA Today called on Novo Nordisk and Eli Lilly to “stop ripping off Americans” with “unconscionably high prices” for their GLP-1 medicines. https://hubs.li/Q02Ff_mJ0
BioSpace’s Post
More Relevant Posts
-
Despite an uncertain legislative path to becoming law, the BIOSECURE Act has already impacted the biopharma industry’s confidence in Chinese service providers and prompted efforts to diversify manufacturing partners. https://hubs.li/Q02FfWYy0
BIOSECURE Act Erodes Industry Confidence in Chinese Contractors: Report | BioSpace
biospace.com
-
Biopharma Layoff Tracker 2024: Apollomics, CureVac, Takeda and More Cut Staff https://hubs.li/Q02FfXbg0
Biopharma Layoff Tracker 2024: Apollomics, CureVac, Takeda and More Cut Staff | BioSpace
biospace.com
-
Taysha Gene Therapies looks to move past its pipeline culls and staff reductions by moving its lead asset into a possible billion-dollar market. https://hubs.li/Q02Ff_nC0
Taysha Shares Positive Rett Results in Bid to Move Past Roadblocks | BioSpace
biospace.com
-
As congressional pressure increases on WuXi AppTec and other China-based companies over alleged ties to the Chinese government, India’s contract development and manufacturing organization sector could benefit. https://hubs.li/Q02FfW550
Scrutiny of WuXi Raises Potential Opportunities for Indian CDMOs | BioSpace
biospace.com
-
Two CRLs from the FDA last week cited concerns with third-party manufacturers, while Indian CDMOs may make a bid for U.S. business if there is a decoupling from Chinese companies under the BIOSECURE Act. https://hubs.li/Q02Ff_tc0
FDA Approves Lilly’s Donanemab While Rejections Highlight Manufacturing Issues | BioSpace
biospace.com
-
Johnson & Johnson and Legend Biotech's Carvykti cell therapy significantly improved survival in patients with multiple myeloma when used in the second-line setting, the companies announced on Tuesday. https://hubs.li/Q02FdD7z0 #pharma #biospace
J&J, Legend’s Phase III Win Cements Carvykti as Earlier-Line Multiple Myeloma Treatment | BioSpace
biospace.com
-
GSK on Wednesday restructured its contract with CureVac to gain access to the biotech’s influenza and COVID-19 programs for $430 million upfront and up to $1.13 billion in future payments. https://hubs.li/Q02Fdyvz0 #pharma #biospace
GSK Pays $430M Upfront for CureVac’s COVID-19, Flu mRNA Vaccines | BioSpace
biospace.com
-
In one of the year’s most highly anticipated decisions, the FDA on Tuesday approved Eli Lilly and Company's donanemab, an anti-amyloid antibody designed as the third drug to modify the course of Alzheimer’s disease. https://hubs.li/Q02FdtkW0 #pharma #biospace
FDA Approves Eli Lilly’s Donanemb to Treat Alzheimer’s Disease | BioSpace
biospace.com
-
Eli Lilly and Company is expanding its radiopharmaceutical portfolio with a $140 million upfront payment to Radionetics Oncology and the exclusive future right to acquire the biotech for $1 billion. https://hubs.li/Q02F2nlJ0 #pharma #biospace
Lilly Inks Radiopharma Deal With Radionetics, Secures Right to Buy Biotech | BioSpace
biospace.com
Drug Discovery | Innovation | Business Development & Strategy | Entrepreneurship
3dI'd advise everyone to check out No Patient Left Behind and the concept of "investing" in innovation as a society. Price controls would be very dangerous for the future of drug discovery. It could stifle innovation and slow the progress of medical advancements. Unfortunately, it is very complicated but everyone should understand the investment we need to make as society to ensure we continue to come up with life changing and life saving drugs. This does come with some higher initial drug prices. We are not paying for just the drug you see but all the innovation that had to occur to get there which does include A LOT of failures in drug discovery which are very expensive and future innovation to make the next amazing drug which has a lot of failures and is very expensive. Just think about what this may do long term for drug innovation. I can promise price controls will not have the long term result you are hoping for.